Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Moss

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Anesthesiology|February 24, 2012
The μ-opioid receptor in cancer progression: is there a direct effect?Frances E Lennon, Jonathan Moss, Patrick A Singleton
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 5, 2010
Cortical and thalamic innervation of direct and indirect pathway medium-sized spiny neurons in mouse striatumNatalie M Doig, Jonathan Moss, J Paul Bolam
Trends in Neurosciences|December 14, 2020
A Vessel for Change: Endothelial Dysfunction in Cerebral Small Vessel DiseaseSophie Quick, Jonathan Moss, Rikesh M Rajani, et al.
Molecular Cancer Therapeutics|June 21, 2008
Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesisPatrick A Singleton, Joe G N Garcia, Jonathan Moss
Anesthesia and Analgesia|November 21, 2008
Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexoneMichael Woo, Michael O'Connor, Chun-Su Yuan, et al.
The Journal of Vascular Access|September 10, 2015
Exploring attitudes towards a randomised controlled trial of venous access devices – a nested pre-trial qualitative studyMoira Ritchie, Linda J Kelly, Jonathan Moss, et al.
Anesthesia and Analgesia|June 29, 2002
Levobupivacaine for axillary brachial plexus block: a pharmacokinetic and clinical comparison in patients with normal renal function or renal diseaseJames C Crews, Robert S Weller, Jonathan Moss, et al.
Cancer|June 5, 2015
The mu opioid receptor: A new target for cancer therapy?Patrick A Singleton, Jonathan Moss, Daniel D Karp, et al.
Cardiovascular and Interventional Radiology|November 13, 2013
Cardiovascular and Interventional Radiological Society of Europe (CIRSE) position statement on renal denervation for resistant hypertensionJonathan Moss, Dierk Vorwerk, Anna Maria Belli, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2003
Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytesWen-Zhe Ho, Chang-Jiang Guo, Chun-Su Yuan, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Anesthesiology|February 24, 2012
The μ-opioid receptor in cancer progression: is there a direct effect?Frances E Lennon, Jonathan Moss, Patrick A Singleton
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 5, 2010
Cortical and thalamic innervation of direct and indirect pathway medium-sized spiny neurons in mouse striatumNatalie M Doig, Jonathan Moss, J Paul Bolam
Trends in Neurosciences|December 14, 2020
A Vessel for Change: Endothelial Dysfunction in Cerebral Small Vessel DiseaseSophie Quick, Jonathan Moss, Rikesh M Rajani, et al.
Molecular Cancer Therapeutics|June 21, 2008
Synergistic effects of methylnaltrexone with 5-fluorouracil and bevacizumab on inhibition of vascular endothelial growth factor-induced angiogenesisPatrick A Singleton, Joe G N Garcia, Jonathan Moss
Anesthesia and Analgesia|November 21, 2008
Reversal of opioid-induced gastric dysfunction in a critically ill burn patient after methylnaltrexoneMichael Woo, Michael O'Connor, Chun-Su Yuan, et al.
The Journal of Vascular Access|September 10, 2015
Exploring attitudes towards a randomised controlled trial of venous access devices – a nested pre-trial qualitative studyMoira Ritchie, Linda J Kelly, Jonathan Moss, et al.
Anesthesia and Analgesia|June 29, 2002
Levobupivacaine for axillary brachial plexus block: a pharmacokinetic and clinical comparison in patients with normal renal function or renal diseaseJames C Crews, Robert S Weller, Jonathan Moss, et al.
Cancer|June 5, 2015
The mu opioid receptor: A new target for cancer therapy?Patrick A Singleton, Jonathan Moss, Daniel D Karp, et al.
Cardiovascular and Interventional Radiology|November 13, 2013
Cardiovascular and Interventional Radiological Society of Europe (CIRSE) position statement on renal denervation for resistant hypertensionJonathan Moss, Dierk Vorwerk, Anna Maria Belli, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2003
Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytesWen-Zhe Ho, Chang-Jiang Guo, Chun-Su Yuan, et al.
Pageof 7